Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
4/2017 | Dogma Therapeutics | Series A | 3.5M |
4/2021 | Riparian Pharmaceuticals | Series A | - |
9/2016 | VivaVision Biotech | Series A | 2.4M |
7/2018 | Anji Pharmaceuticals | Seed Round | 9M |
1/2020 | Proviva Therapeutics | Seed Round | - |
10/2021 | Arthrosi Therapeutics | Series C | 14.3M |
2/2021 | Blue Oak Pharmaceuticals | Series A | 9M |
10/2018 | Riparian Pharmaceuticals | Series A | 3M |
9/2019 | VivaVision Biotech | Series C | 9.1M |
8/2021 | Basking Biosciences | Seed Round | - |
10/2020 | Sisu Pharma | Seed Round | 1.7M |
7/2020 | Clues Therapeutics Inc. | Convertible Note | 1.3M |
4/2016 | Tabomedex Biosciences, Inc. | Series A | 5M |
5/2020 | Diagon, Inc. | Convertible Note | 5M |
9/2018 | Clues Therapeutics Inc. | Seed Round | 800k |
8/2018 | Tekeluo Biotech | Series A | 4.7M |
1/2018 | Bonti | Series C | 15.5M |
4/2017 | Bonti | Series B | 11.7M |
11/2016 | Flash Therapeutics | Series A | 5M |
2/2021 | Seraxis | Series C | 40M |
8/2018 | SQZ Biotech | Series C | 0 |
7/2016 | Epican Technology Hongkong Limited | Series A | 5.3M |
7/2020 | Anji Pharmaceuticals | Series A | 12M |
6/2018 | Viva Biotech | Venture Round | 30M |
6/2019 | Anji Pharmaceuticals | Series A | 14M |
10/2021 | Arthrosi Therapeutics | Series C | 0 |
8/2021 | Basking Biosciences | Seed Round | - |
4/2021 | Riparian Pharmaceuticals | Series A | - |
2/2021 | Seraxis | Series C | 0 |
2/2021 | Blue Oak Pharmaceuticals | Series A | 0 |
10/2020 | Sisu Pharma | Seed Round | 0 |
7/2020 | Clues Therapeutics Inc. | Convertible Note | 0 |
7/2020 | Anji Pharmaceuticals | Series A | 0 |
5/2020 | Diagon, Inc. | Convertible Note | 0 |
1/2020 | Proviva Therapeutics | Seed Round | - |
Name | Price |
---|
Name | Size | Announced Date |
---|